The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patterns of split-dose gemcitabine and cisplatin (GC) use in patients with locally advanced or metastatic urothelial carcinoma (la/mUC): Results of a 10-country physician survey.
 
Richard O'Dwyer
Speakers' Bureau - Merck KGaA
 
Sophia Junker
Employment - Cytel Inc., which was contracted by the healthcare business of Merck KGaA, Darmstadt, Germany to conduct this research
 
Robert Szulkin
Employment - Cytel Inc., which was contracted by the healthcare business of Merck KGaA, Darmstadt, Germany to conduct this research
 
Scarlette Kienzle
Employment - Cytel Inc., which was contracted by the healthcare business of Merck KGaA, Darmstadt, Germany to conduct this research
 
Mairead Kearney
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA; Novartis; UCB
 
Srikala Sridhar
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Gilead Sciences (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
Research Funding - Bayer (Inst); Janssen (Inst); Pfizer (Inst)